文献速递乳房整形与再造

全肌肉覆盖与脱细胞真皮基质在假体乳房再造中的比较

Total Muscle Coverage versus AlloDerm Human Dermal Matrix for Implant-Based Breast Reconstruction.
PubMed 文献 · Plast Reconstr Surg · 2019-01-01

AlloDerm组总体并发症(20.5% vs 8.8%,p=0.005)和主要并发症(13.7% vs 5.1%,p=0.0001)显著更高,但初始填充量更大、扩张次数更少;全肌肉覆盖仍是质量可靠且不增加并发症的选择。

要点

  • AlloDerm组总体并发症20.5%、主要并发症13.7%,均显著高于全肌肉覆盖组。
  • AlloDerm组初始填充量更高、扩张次数更少,但未缩短换假体时间。
  • 每侧乳房使用AlloDerm平均增加费用2217美元。

核心结论

  • AlloDerm可增加初始填充量并减少扩张次数,但并发症风险和费用更高,全肌肉覆盖仍是不增加并发症的优质选择。

主要发现

  • AlloDerm组总体并发症20.5% vs 全肌肉覆盖组8.8%(p=0.005),主要并发症13.7% vs 5.1%(p=0.0001)。
  • 全肌肉覆盖组平均初始填充量54±47,低于AlloDerm组167±139(p=0.00003)。
  • 全肌肉覆盖组扩张次数8.1次多于AlloDerm组5.8次(p=0.000051),完全扩张时间60.2天 vs 43.3天(p=0.0002)。
  • 换假体时间162.4天 vs 162.3天(p=0.13),两组无显著差异。
  • 每侧乳房使用AlloDerm平均增加费用2217美元。

临床怎么用

  • 对假体乳房再造患者,选择AlloDerm需权衡并发症风险与费用,尤其双侧再造时更应审慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Prosthetic breast reconstruction is the most common method for treatment of patients undergoing mastectomy. Acellular dermal matrix has become more popular in implant-based breast reconstruction. METHODS: The authors conducted a retrospective review of all patients undergoing prosthetic breast reconstruction between August of 2002 and December of 2013. Patients were analyzed in terms of demographics, fill volumes, number of expansions, costs, and complications. RESULTS: A total of 284 patients underwent mastectomy surgery with 481 implant-based breast reconstructions. Four hundred eight tissue expanders had total muscle coverage, whereas 73 had AlloDerm. The rate of overall complications and major complications was significantly higher in the AlloDerm group: 20.5 percent versus 8.8 percent (p = 0.005), and 13.7 percent versus 5.1 percent (p = 0.0001), respectively. The mean initial fill volume was significantly lower in the total muscle coverage group compared to the acellular dermal matrix group (54 ± 47 versus 167 ± 139; p = 0.00003), resulting in a higher number of expansions (8.1 versus 5.8; p = 0.000051) and longer time to full expansion (60.2 days versus 43.3 days; p = 0.0002). This did not translate into a faster time to expander exchange (162.4 days versus 162.3 days; p = 0.13). Use of AlloDerm added a mean cost of $2217 for each breast. CONCLUSIONS: Implant-based breast reconstruction has evolved with the advent of acellular dermal matrices. Although the use of acellular dermal matrix allows increased initial fill volumes and fewer total expansions, there is an increased risk of complications and increased costs, especially in patients undergoing bilateral reconstruction. Total muscle coverage remains an excellent option for providing quality breast reconstruction without increased complications. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Ivey JS, Abdollahi H, Herrera FA, et al. Total Muscle Coverage versus AlloDerm Human Dermal Matrix for Implant-Based Breast Reconstruction. Plast Reconstr Surg. 2019. PMID: 30589768. doi:10.1097/PRS.0000000000005076

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。